These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29984479)

  • 21. Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration.
    Sakloetsakun D; Dünnhaupt S; Barthelmes J; Perera G; Bernkop-Schnürch A
    Int J Biol Macromol; 2013 Oct; 61():363-72. PubMed ID: 23933302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug.
    Fabiano A; Piras AM; Uccello-Barretta G; Balzano F; Cesari A; Testai L; Citi V; Zambito Y
    Eur J Pharm Biopharm; 2018 Sep; 130():281-289. PubMed ID: 30006244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation
    Li F; Chen X; He Y; Peng Z
    ACS Appl Bio Mater; 2024 Mar; 7(3):1976-1989. PubMed ID: 38447202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ternary polymeric nanoparticles for oral siRNA delivery.
    Zhang J; He C; Tang C; Yin C
    Pharm Res; 2013 May; 30(5):1228-39. PubMed ID: 23307349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel ligand conjugated nanoparticles for oral insulin delivery.
    Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y
    Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
    Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
    Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of Virus-Mimicking Polyelectrolyte Complexes for Enhanced Oral Insulin Delivery.
    Liu C; Xu H; Sun Y; Zhang X; Cheng H; Mao S
    J Pharm Sci; 2019 Oct; 108(10):3408-3415. PubMed ID: 31176647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
    Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
    Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
    Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment.
    Shi Y; Liu L; Yin M; Zhao Z; Liang Y; Sun K; Li Y
    J Drug Target; 2023 Jan; 31(1):65-73. PubMed ID: 35861405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
    Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
    Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration.
    Hecq J; Siepmann F; Siepmann J; Amighi K; Goole J
    Drug Dev Ind Pharm; 2015; 41(12):2037-44. PubMed ID: 26006329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.